PRLD icon

Prelude Therapeutics
PRLD

Overview Fund Activity

70 hedge funds and large institutions have $74M invested in Prelude Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 7 closing their positions.

Holders
70
Holders Change
+9
Holders Change %
+14.75%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
20
Reduced
21
Closed
7
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$3K

Top Buyers

1
ECM
1
ExodusPoint Capital Management
New York
$1.91M
2
APM
2
Avidity Partners Management
Texas
$1.84M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$743K
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$583K
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$2.27M

Top Sellers

1
BC
1
Boxer Capital
California
$3.54M
2
SCM
2
Sio Capital Management
New York
$0
3
DM
3
Deerfield Management
New York
$7.8M
4
KCM
4
Kennedy Capital Management
Missouri
$0
5
YIH
5
Y-Intercept (HK)
Hong Kong
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Nisa Investment Advisors
76
Nisa Investment Advisors
Missouri
– – -2,100 Closed
Carson Wealth (CWM LLC)
77
Carson Wealth (CWM LLC)
Nebraska
$0 10 -12 -55%
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4